Does tirzepatide affect your period?

6 min read

Written by: 

Grace Gallagher

Reviewed by: 

Raagini Yedidi, MD

Updated:  Jun 11, 2026

Trusted source badge

Reviewed By

Raagini Yedidi, MD

Raagini Yedidi, MD, is an internal medicine resident and medical reviewer for Ro.

View bio

Key takeaways

  • Changes to menstrual cycles are not listed as specific side effects in the prescribing information for tirzepatide.

  • However, significant, rapid weight loss can mess with your menstrual cycle, which may explain why some people experience missed, irregular, lighter, or shorter periods while taking tirzepatide. 

  • For some people, particularly those with PCOS/PMOS or obesity-related heavy periods, tirzepatide may actually lead to more regular, lighter, or shorter cycles.

  • If you notice any significant menstrual changes, like missed periods, unusually heavy bleeding, or severe pain,  speak to a healthcare provider.

Here's what we'll cover

Here's what we'll cover

Key takeaways

  • Changes to menstrual cycles are not listed as specific side effects in the prescribing information for tirzepatide.

  • However, significant, rapid weight loss can mess with your menstrual cycle, which may explain why some people experience missed, irregular, lighter, or shorter periods while taking tirzepatide. 

  • For some people, particularly those with PCOS/PMOS or obesity-related heavy periods, tirzepatide may actually lead to more regular, lighter, or shorter cycles.

  • If you notice any significant menstrual changes, like missed periods, unusually heavy bleeding, or severe pain,  speak to a healthcare provider.

If you’re thinking about taking a GLP-1 medication for weight loss or are already on that train, you’re likely wondering how the medication can affect all aspects of your health, not just the number on the scale. For example, does tirzepatide affect your period? And if it does, what can you expect when it comes to tirzepatide and the menstrual cycle?

Well, for starters, there’s no clinical research that tirzepatide itself will influence your period, but weight loss (which happens as a result of tirzepatide) certainly can have ramifications for your cycle. We’ll dive in below.

Does tirzepatide affect your period?

Tirzepatide can indirectly affect your period, primarily through weight loss rather than any direct hormonal mechanism. 

Tirzepatide (Zepbound, Mounjaro) is a dual GIP/GLP-1 receptor agonist, meaning it targets two distinct hormone receptors (GIP and GLP-1) — neither of which is a sex hormone. However, research shows that the weight loss and insulin-sensitivity effects of tirzepatide can interact with reproductive hormones, primarily through weight loss.

Changes to your menstrual cycle, including irregular or missed periods, spotting, or any other menstrual irregularities, are not common tirzepatide side effects. But if you think your menstrual cycle is different since you started taking tirzepatide, it’s not all in your head. 

Weight loss is known to affect the menstrual cycle, and moving out of the range of obesity may also lead to hormonal changes that influence menstruation.

We’ll go into more detail below.

Tirzepatide and menstrual cycle changes: how can it affect your period? 

Here are some ways weight loss from tirzepatide may impact your menstrual cycle (though not everyone will experience changes).

Skipped or missed periods

Losing a significant amount of weight in a short period of time — which often occurs while taking tirzepatide — can disrupt the menstrual cycle. A 2023 research review found that losing ~10%–15% of body weight relatively quickly may lead to amenorrhea (the medical term for three or more months of missed periods that aren’t a result of menopause or pregnancy). 

That level of weight loss can potentially occur with tirzepatide. In clinical trials of Zepbound, participants taking 15 mg lost as much as 21% of their body weight over 72 weeks, though results varied from person to person.

It’s important to note that missed periods are not considered a direct side effect of tirzepatide. However, some people taking the medication may experience changes to their menstrual cycle because of the rapid or significant weight loss that can occur while using it.

Irregular periods

After significant weight loss, a period that once ran like clockwork may start marching to its own slightly unpredictable rhythm. Weight loss–related amenorrhea can last for months or even years, according to the aforementioned research review.

Weight loss can cause you to skip a period altogether or make your cycle longer (more days between periods).

Again, tirzepatide itself isn’t known to directly cause irregular periods. However, because the medication can lead to significant weight loss, some people may notice changes in their cycle while their body adjusts. If you experience changes in your menstrual cycle while taking tirzepatide, it’s a good idea to let your healthcare provider know.

Lighter flow

Research shows that women with higher body mass indices (BMIs) tend to have heavier periods, and having obesity increases the risk of heavy, painful periods.  

Why’s that? Well, research suggests that adipose tissue (body fat) produces hormones, including estrogen, that may directly influence the uterine lining and contribute to heavier menstrual bleeding in people with higher BMIs. 

(Fun fact: After menopause, the body’s estrogen primarily comes from body fat. The decline in ovarian estrogen during menopause is associated with an increase in abdominal fat.)

Medically, a period is considered “heavy” if a person loses more than 80 mL (2.7 oz) of blood during one menstrual cycle — that’s about a shot glass and a half. But you’re probably not out there measuring your cycle in ounces. So, put another way, heavy menstruation usually requires a new pad or tampon every 1–2 hours.

If you have heavy periods, you may find that losing weight while on tirzepatide gives you a lighter flow.

Shorter periods

A heavy period doesn’t always mean a heavy flow. It can also mean bleeding for more than a week or seven days. Now, tirzepatide isn’t going to magically shave days off of your period (though that would be nice). But by causing significant weight loss, it may shorten your flow to the average 3–7 days — especially if your heavy period is caused by obesity or overweight. 

More regulated cycles 

For some folks, tirzepatide may cause irregular periods. For others, it may lead to more regular periods. Reason being having a higher BMI can contribute to irregular cycles. So, decreasing your BMI through weight loss (see: tirzepatide) may help your body settle into a more predictable menstrual rhythm. 

This is especially possible for people with polycystic ovary syndrome (PCOS), which is now also known as polyendocrine metabolic ovarian syndrome or PMOS. One study found that among women with PCOS/PMOS, about 85% had irregular periods before treatment, and that number dropped to around 32% after taking tirzepatide. Ovarian cysts also became significantly less common.

Fertility changes 

Weight loss from tirzepatide can potentially influence fertility in both directions. 

For example, there’s some evidence that tirzepatide can improve fertility indirectly by aiding in weight loss and potentially restoring ovulation in those with obesity-related anovulation or PCOS/PMOS. However, if significant, rapid weight loss leads to missed periods, it may also mean ovulation has stopped, which can make getting pregnant more difficult.

Tirzepatide is not recommended during pregnancy or while trying to get pregnant. Due to the potential for fetal harm, the US Food and Drug Administration (FDA) recommends stopping tirzepatide immediately upon finding out you’re pregnant. 

If you are planning a pregnancy, speak to your healthcare provider regarding how far in advance you should stop tirzepatide. 

On the topic of conception, it’s also worth noting that tirzepatide can reduce the effectiveness of oral birth control pills because it slows stomach emptying. This is especially true when starting treatment or increasing the dose. As such, it’s recommended to use a non-oral contraceptive or backup method for four weeks after starting tirzepatide and for four weeks after every dose increase. 

Can tirzepatide make you miss a period?

Not exactly. There’s no direct evidence that tirzepatide itself causes missed periods, especially with gradual and moderate weight loss. However, significant and rapid weight loss (which, again, is common on tirzepatide) can disrupt your cycle, potentially causing irregular or missed periods.

Does tirzepatide affect female hormones?

Yes, indirectly. Tirzepatide has been shown to improve the body’s response to insulin and to help manage blood sugar. 

In people with insulin resistance — particularly those with PCOS/PMOS — elevated insulin levels can stimulate excess androgen (i.e. male hormone) production and suppress sex hormone-binding globulin (SHBG). This may disrupt the balance of reproductive hormones such as estrogen and progesterone. 

By improving insulin sensitivity, tirzepatide may help reduce this hormonal imbalance in some people. That being said, direct evidence for this specifically is still limited in humans.

Fastest-working GLP-1 for faster weight loss

What to do if you experience menstrual changes on tirzepatide

Some changes to your menstrual cycle may be welcome, such as shorter or lighter periods. In general, if you notice changes to your period while taking tirzepatide, there are a few simple things you can do:

  • Talk to your healthcare provider. Missed periods, unusually heavy bleeding, or severe pain are always worth a conversation with your healthcare provider. If you’re not experiencing your monthly flow, they’ll likely advise you to take a pregnancy test. And they can help guide the next steps to get your cycle back on track.

  • Keep track of your cycle. In addition to tracking when your period starts, it can be really helpful to note the duration and heaviness of your flow. This way, you can share this information with your healthcare provider, and they can then use it to best determine what might be behind any menstrual cycle changes on tirzepatide.  

  • Stay hydrated. Drinking enough water consistently throughout the day can help mitigate unpleasant period side effects of tirzepatide, such as bloating and constipation. Research shows drinking water can help reduce pain sensitivity, which may help with cramps.

  • Prioritize iron-rich foods. Heavy periods can deplete iron levels, leading to fatigue. Iron-rich foods like lean meat, spinach, lentils, and fortified cereals can help keep your levels up. A balanced diet helps support hormone health.

  • Manage stress. High stress can throw your cycle off. Practices like sleep, mindfulness, gentle yoga, or short breaks throughout the day can support your overall hormonal health.

  • Eat enough calories. Tirzepatide can reduce your appetite, but it’s still important to get adequate calories. The number of calories needed per day varies depending on factors such as age, weight, sex, and activity levels. So, it’s a good idea to consult your healthcare provider or a registered dietician if you’re unsure how to eat enough calories while maintaining weight loss. Ro’s calorie deficit calculator can help, too.

Find your recommended calorie deficit

A calorie deficit happens when you consume fewer calories than you burn. It’s key to weight loss and can help guide your nutrition strategy. Use the tool below to estimate how many calories you need each day to reach your weight loss goals safely.

Maintain your current weight

----

cal daily

Lose one pound per week

----

cal daily

Time to achieve your __ goal weight

----

Weeks

This calculator is for informational purposes only and not a substitute for medical advice. Individual needs vary. Consult a healthcare provider before making changes. Eating fewer than 1,200 (women) or 1,500 (men) calories a day is not recommended.

Bottom line

So, does tirzepatide affect your period? It can, but not directly. In other words, menstrual changes experienced on tirzepatide are likely due to weight loss caused by the medication, not the medication itself. Here’s what to keep in mind: 

  • Weight loss — especially significant, rapid weight loss such as that commonly experienced on tirzepatide — can affect your menstrual cycle. More specifically, it can cause irregular, lighter, or shorter periods, among other menstrual cycle changes. 

  • While some people might notice more irregular cycles on tirzepatide, others may start to have a more regular cycle. Research shows the latter can be especially true of those with PCOS/PMOS, thanks to the drug’s ability to improve insulin sensitivity and promote weight loss. 

  • If you experience any period changes while taking tirzepatide, it’s always a good idea to consult your healthcare provider. Missed periods, unusually heavy bleeding, and/or severe pain are not worth shrugging off as “just a side effect” of tirzepatide. 

Frequently asked questions (FAQs)

DISCLAIMER

If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.

GLP-1 Important Safety Information: Read more about serious warnings and safety info.

Zepbound Important Safety Information: Read more about serious warnings and safety info.

Mounjaro Important Safety Information: Read more about serious warnings and safety info.

References

  • Chavda, V. P., Ajabiya, J., Teli, D., et al.(2022). Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: A mini-review. Molecules, 27(13), 4315. doi: 10.3390/molecules27134315. Retrieved from https://www.mdpi.com/1420-3049/27/13/4315

  • Chen, L., Lu, Y., Zhou, Y. F., et al. (2023). The effects of weight loss-related amenorrhea on women's health and the therapeutic approaches: A narrative review. Annals of Translational Medicine, 11(2), 132. doi: 10.21037/atm-22-6366. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9929756/

  • Ding, H., Zhang, J., Zhang, F., et al. (2021). Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome. Frontiers in Endocrinology, 12, 741764. doi: 10.3389/fendo.2021.741764. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8564180/

  • Ferdous, J., Hossain, M. M., Faika, M. J., & Begum, M. (2025). Role of tirzepatide in obesity management among women with polycystic ovary syndrome. International Journal of Diabetes and Endocrinology, 10(2), 37–44. doi: 10.11648/j.ijde.20251002.12. Retrieved from

  • Gupta, H. (2025). The role of nutrition in menstrual cycle regularity and the management of menstrual disorder: A review. International Journal of Innovative Science and Research Technology, 10(4). doi: 10.38124/ijisrt/25apr2298. Retrieved from https://www.ijisrt.com/the-role-of-nutrition-in-menstrual-cycle-regularity-and-the-management-of-menstrual-disorder-a-review

  • InformedHealth.org [Internet]. (Updated 2025). Overview: Heavy periods. Cologne, Germany: Institute for Quality and Efficiency in Health Car. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK279294/

  • Itriyeva, K. (2022). The effects of obesity on the menstrual cycle. Current Problems in Pediatric and Adolescent Health Care, 52(8), 101241. doi: /10.1016/j.cppeds.2022.101241. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9449629/

  • Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216. doi: 10.1056/nejmoa2206038. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

  • Khan, D., Ojo, O. O., Woodward, O. R., et al. (2022). Evidence for involvement of GIP and GLP-1 receptors and the gut-gonadal axis in regulating female reproductive function in mice. Biomolecules, 12(12), 1736. doi: 10.3390/biom12121736. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9775379/

  • Mair, K. M., Gaw, R., & MacLean, M. R. (2020). Obesity, estrogens and adipose tissue dysfunction – implications for pulmonary arterial hypertension. Pulmonary Circulation, 10(3), 2045894020952019. doi: 10.1177/2045894020952023. Retrieved from https://onlinelibrary.wiley.com/doi/10.1177/2045894020952023

  • Manzalji, K. M. B., Alna'amneh, S., & Humaida, S. M. A. (2025). The impact of GLP-1 receptor agonists on human fertility: A narrative review of the reproductive effects of semaglutide (Ozempic) and tirzepatide (Mounjaro) in men and women. Scholars Journal of Medical Case Reports, 13(11). doi: 10.36347/sjmcr.2025.v13i11.027. Retrieved from https://doi.org/10.36347/sjmcr.2025.v13i11.027

  • Moustarah, F. & Daley, S. F. (2024). Dietary iron. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK459224/

  • Munro, M. G., Mast, A. E., Powers, J. M., et al. (2023). The relationship between heavy menstrual bleeding, iron deficiency, and iron deficiency anemia. American Journal of Obstetrics and Gynecology, 229(1), 1–9. doi: 10.1016/j.ajog.2023.01.017. Retrieved from https://www.ajog.org/article/S0002-9378(23)00033-6/fulltext

  • Poitras, M., Shearzad, F., Qureshi, A. F., et al. (2024). Bloody stressed! A systematic review of the associations between adulthood psychological stress and menstrual cycle irregularity. Neuroscience & Biobehavioral Reviews, 163. doi: 10.1016/j.neubiorev.2024.105756. Retrieved from https://www.sciencedirect.com/science/article/pii/S0149763424002756

  • Reavey, J. J., Walker, C., Murray, A. A., et al. (2021). Obesity is associated with heavy menstruation that may be due to delayed endometrial repair. The Journal of Endocrinology, 249(2), 71–82. doi: 10.1530/JOE-20-0446. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33836495/

  • Thomas, M. K., Nikooienejad, A., Bray, R., et al. (2020). Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism, 106(2), 388. doi: 10.1210/clinem/dgaa863. Retrieved from: https://academic.oup.com/jcem/article/106/2/388/6000489

  • Torkan, B., Mousavi, M., Dehghani, S., et al. (2021). The role of water intake in the severity of pain and menstrual distress among females suffering from primary dysmenorrhea: A semi-experimental study. BMC Women's Health, 21, 40. doi: 10.1186/s12905-021-01184-w. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33509179/

  • Unluhizarci, K., Karaca, Z., & Kelestimur, F. (2021). Role of insulin and insulin resistance in androgen excess disorders. World Journal of Diabetes, 12(5), 616. doi: 10.4239/wjd.v12.i5.616. Retrieved from https://www.wjgnet.com/1948-9358/full/v12/i5/616.htm

  • U.S. Food & Drug Administration (FDA). (2026). Highlights of Prescribing Information: Zepbound (tirzepatide injection, for subcutaneous use). Retrieved from https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/d2d7da5d-ad07-4228-955f-cf7e355c8cc0/spl-doc?hl=tirzepatide

  • Zheng, L., Yang, L., Guo, Z., Yao, N., et al. (2024). Obesity and its impact on female reproductive health: Unraveling the connections. Frontiers in Endocrinology, 14. doi: 10.3389/fendo.2023.1326546. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10803652

What’s included

Provider consultation

GLP-1 prescription (if appropriate)

Insurance coverage & paperwork handled

Ongoing care & support

Tools to track progress

Please note: The cost of medication is not included in the Ro Body membership.